Glythera, a biotech spin-out from the University of Bath, has raised £700k ($1m) from commercialisation company the IP Group. The funding is the result of the UK-based firm hitting commercial milestones following a £600k investment from the IP Group last year, which was used to entice Glythera to relocate in the north east of England.…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
